Now live: Pro — the full 13F research suite for serious investorsSee pricing →
CARNEGIE MELLON UNIVERSITY

Q4 2023 · 13F-HR

CARNEGIE MELLON UNIVERSITYholdings as filed

Filed 2024-02-02 · accession 0000898432-24-000074

$82.9M
Reported value
6
Positions
2023-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
26603R106DUOLDUOLINGO INC$82.2M99.1%362,314CommonSOLE
142922103CARMELL CORPORATION$392,6620.47%103,061CommonSOLE
92337R101VERAVERA THERAPEUTICS INC$247,0030.30%16,060CommonSOLE
64132K201OHRPEURNEUBASE THERAPEUTICS INC$34,7620.04%46,970CommonSOLE
74039M309POAIEURPREDICTIVE ONCOLOGY INC$34,0780.04%10,358CommonSOLE
457919108IHTINNSUITES HOSPITALITY TRUST$16,9000.02%10,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.